Table 2.
Type | Number | %* |
Vinorelbine alone | 16 | 23 |
Vinorelbine + T | 32 | 46 |
Vinorelbine + Infusional 5-FU or Capecitabine | 8 | 11 |
Vinorelbine + Infusional 5-FU or Capecitabine + T | 3 | 4 |
Vinorelbine + Gemcitabine | 8 | 11 |
Vinorelbine + other agents** | 3 | 4 |
Legend: T, trastuzumab
*Because of rounding sum of percentages does not equal 0.
**1 patients in this group received also trastuzumab